' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

SARS-CoV-2 IgG Levels Allow Predicting the Optimal Time Span of Convalescent Plasma Donor Suitability.
Laner-Plamberger, S; Lindlbauer, N; Weidner, L; Gänsdorfer, S; Weseslindtner, L; Held, N; Lauth, W; Zimmermann, G; Kern, JM; Föttinger, F; Ombres, L; Jungbauer, C; Rohde, E; Grabmer, C;
Diagnostics (Basel). 2022; 12(11):
Originalarbeiten (Zeitschrift)


Grabmer Christoph
Jungbauer Christof
Kern Jan Marco
Laner-Plamberger Sandra
Rohde Eva
Zimmermann Georg Johannes


Convalescent plasma (CP) has been in use for the treatment of numerous infectious diseases for more than a century, recently also for coronavirus disease 2019 (COVID-19). A major challenge for this treatment is identifying suitable donors with sufficient levels of functional antibodies and to determine the optimal time span for CP donation. In this retrospective study, we analyzed 189 CP donations of 66 donors regarding anti-SARS-CoV-2 anti-S IgG antibody levels. We found a significant correlation between the semi-quantitative SARS-CoV-2 IgG ratio values and in vitro antibody functionality. A time-to-event analysis allowed us to predict the optimal time span of COVID-19 CP donor suitability. We found that high IgG ratio values, which significantly correlate with high in vitro antibody functionality, were suitable for CP donation for a median of 134 days after the first CP donation. Donors with lower IgG ratios were suitable for a median of 53 days. Our data support plasma collection centers to determine optimal points in time for CP donation by means of widely used semi-quantitative laboratory IgG ratio values.

Find related publications in this database (Keywords)

convalescent plasma
SARS-CoV-2 antibodies